Pricing
  1. JP-listed companies
  2. Qol Holdings Co.,Ltd.
  3. Financials
  4. Accounts receivable, net

Qol Holdings Co.,Ltd.【JP:3034】

Market cap
¥68.8B
P/E ratio
9.5x
Cure All Holdings operates pharmacies, provides business outsourcing services to pharmaceutical companies, and manufactures drugs to support healthcare across communities.
SummaryFinancialsDividendsHistorySegmentsOwnershipWorkforce
Period EndAccounts receivable, net (Million JPY)YoY (%)
Mar 31, 202521,377+26.42%
Mar 31, 202416,909-0.25%
Mar 31, 202316,951-2.48%
Mar 31, 202217,382-4.66%
Mar 31, 202118,231-20.26%
Mar 31, 202022,862+31.92%
Mar 31, 201917,330+4.15%
Mar 31, 201816,640+5.42%
Mar 31, 201715,785+3.56%
Mar 31, 201615,242+26.19%
Mar 31, 201512,079

Income Statement

RevenueRevenue growth (%)Cost of revenueGross profitGross margin (%)Research & developmentSelling, general & administrativeOperating margin (%)Operating expenses Operating income Income before tax Pretax margin (%)Provision for income taxesEffective tax rate (%)Net income Net income margin (%)Earnings per shareDiluted EPSDividend payout ratio (%)Dividend per shareEBITDAEBITDA margin (%)

Balance Sheet

Cash and cash equivalents Marketable securities, current Total cash & short-term investmentsAccounts receivable, netInventoriesTotal current assetsProperty, plant and equipment, netMarketable securities, non-current Total non-current assetsTotal assets Accounts payableShort-term debtLong-term debt, current Total current liabilitiesLong-term debt, non-current Total non-current liabilitiesTotal liabilities Common stock and paid-in capital Retained earningsStockholders' equityTotal debtNet debtD/E ratio (%)Working capital

Cash Flow

Depreciation & amortizationStock-based compensationCash from operations Capital expendituresCash from investing Payments for dividends Repurchases of common stockProceeds from issuance of term debt, netRepayments of term debtCash from financing Free cash flowFCF margin (%)